Governance Negative

2026-05-30 15:12

Apollo Hospitals Enterprise Limited announced the resignation of Mr. Dinesh Madhavan, President - Group Oncology and International, who is a Designated Senior Management Personnel of the company. The company has accepted his resignation, which will be effective from the close of business hours on May 30, 2026.

Governance Positive

2026-05-27 17:50

Apollo Hospitals Enterprise Limited submitted its Annual Secretarial Compliance Report for the year ended March 31, 2026. The report confirms full compliance with all applicable SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and other relevant SEBI regulations. There were no observations, non-compliances, or regulatory actions reported by the Practicing Company Secretaries during the review period or in previous reports, and no resignations of statutory auditors.

Business Update Neutral

2026-05-25 16:28

Apollo Hospitals Enterprise Limited has published notices for NCLT-convened meetings of its Secured Creditors, Unsecured Creditors, and Equity Shareholders on June 24, 2026. These meetings, along with a meeting for Keimed Private Limited's unsecured creditors on June 23, 2026, are to consider and approve a Composite Scheme of Arrangement involving Apollo Hospitals Enterprise, Apollo Healthco, Keimed Private, and Apollo Healthtech.

Governance Neutral

2026-05-25 16:27

Apollo Hospitals Enterprise Limited announced the newspaper publication of notices for NCLT-convened meetings of its Secured Creditors, Unsecured Creditors, and Equity Shareholders. These meetings, scheduled for June 24, 2026, at 10:00 a.m., 11:00 a.m., and 2:30 p.m. respectively, are to consider a Composite Scheme of Arrangement, as directed by the Hon'ble National Company Law Tribunal, Chennai Bench.

Business Update Neutral

2026-05-25 15:26

Apollo Hospitals Enterprise Limited announced the availability of the transcript of its presentation on audited financial results for the three months and year ended March 31, 2026. The transcript, from the presentation made on May 21, 2026, is accessible on the company's website.

Business Update Neutral

2026-05-21 22:32

Apollo Hospitals Enterprise Limited announced a meeting of its Secured Creditors on June 24, 2026, at 10:00 a.m. (IST), via video conferencing. The purpose is to consider and approve a composite scheme of arrangement involving the company, Apollo Healthco Limited, Keimed Private Limited, and Apollo Healthtech Limited. This meeting is as per orders from the National Company Law Tribunal. Remote e-voting will be open from June 20 to June 23, 2026.

Governance Neutral

2026-05-21 22:27

Apollo Hospitals Enterprise Limited announced a meeting of its equity shareholders on June 24, 2026, at 2:30 p.m. (IST) via video conferencing. The purpose is to consider and approve a composite scheme of arrangement involving Apollo Hospitals Enterprise Limited (Demerged Company), Apollo Healthco Limited (Transferor Company 1), Keimed Private Limited (Transferor Company 2), and Apollo Healthtech Limited (Resultant Company), as per orders from the NCLT Chennai Bench. E-voting will be available from June 20 to June 23, 2026.

Governance Neutral

2026-05-21 22:27

Apollo Hospitals Enterprise Limited announced a meeting of its unsecured creditors on June 24, 2026, at 11:00 a.m. (IST) via video conferencing. The meeting is convened as per NCLT orders to consider and approve a composite scheme of arrangement among Apollo Hospitals, Apollo Healthco Limited, Keimed Private Limited, and Apollo Healthtech Limited. Unsecured creditors as of December 31, 2025, are eligible to vote, with remote e-voting available from June 20-23, 2026.

Governance Neutral

2026-05-21 22:27

Apollo Hospitals Enterprise Limited has announced a meeting of its equity shareholders on Wednesday, June 24, 2026, at 2:30 p.m. (IST) via Video Conferencing. The meeting is to consider and approve a composite scheme of arrangement involving Apollo Hospitals Enterprise Limited, Apollo Healthco Limited, Keimed Private Limited, and Apollo Healthtech Limited, as per the orders of the National Company Law Tribunal. The cut-off date for e-voting is June 17, 2026, with the e-voting period from June 20, 2026, to June 23, 2026.

Business Update Neutral

2026-05-21 18:04

Apollo Hospitals Enterprise Limited announced the availability of the audio recording of its Analyst Call on the financial results for the three months and year ended March 31, 2026. The recording can be accessed on the Company's website.

Governance Neutral

2026-05-21 13:42

Apollo Hospitals Enterprise Limited announced the re-appointment of Ms. Rama Bijapurkar as an Independent Director for a second term of five consecutive years. Her new term will commence on November 12, 2026, and conclude on November 11, 2031, subject to the approval of shareholders at the ensuing Annual General Meeting.

Business Update Positive

2026-05-20 19:49

Apollo Hospitals Enterprise Ltd announced on May 20, 2026, a combination of its Apollo Cradle and Fertility verticals (through AHLL) with Kids Clinic India Limited's Cloudnine. This transaction creates one of India's largest integrated Maternity and Fertility care Platforms. AHLL's Mother & Child and Fertility businesses are valued at INR 1,550 Crores, and AHLL will hold a 9.9% equity stake, becoming the largest non-financial shareholder with board representation in the combined entity.

Financials Neutral

2026-05-20 19:27

Apollo Hospitals Enterprise Limited provided an update from a Board Meeting on May 20, 2026, clarifying turnover (revenue from operations) and net worth figures for ASHPL and AFCPL. ASHPL's turnover is ₹351.53 crores with a net worth of ₹(153.84) crores. AFCPL's turnover is ₹100.05 crores with a net worth of ₹(38.33) crores.

Financials Positive

2026-05-20 18:21

Standalone Revenue ₹9,326.2Cr vs ₹8,202.1Cr (▲13.7% YoY), EBITDA ₹2,328.0Cr vs ₹2,044.2Cr (▲13.9% YoY), PAT ₹1,492.6Cr vs ₹1,296.3Cr (▲15.1% YoY). EBITDA Margin 25.0% vs 24.9% (▲4bps).

Financials Positive

2026-05-20 18:19

Standalone Revenue ₹9,326.2Cr vs ₹8,202.1Cr (▲13.70% YoY), EBITDA ₹2,328.0Cr vs ₹2,044.2Cr (▲13.88% YoY), PAT ₹1,492.6Cr vs ₹1,296.3Cr (▲15.14% YoY). EBITDA Margin 24.96% vs 24.92% (▲4bps).

Routine Neutral

2026-05-20 18:18

New Filing detected. See link for details.

Financials Positive

2026-05-20 18:00

Standalone Revenue ₹24,385Mn vs ₹20,753Mn (▲17.6% YoY), EBITDA ₹5,955Mn vs ₹5,213Mn (▲14.2% YoY), PAT ₹3,824Mn vs ₹3,334Mn (▲14.7% YoY). EBITDA Margin 24.4% vs 25.1% (▼70bps). The Board also recommended a final dividend of ₹10 per share for FY2025-26.

Financials Positive

2026-05-20 17:58

Consolidated Revenue ₹25,228.5Cr vs ₹21,794Cr (▲15.7% YoY), EBITDA ₹3,795Cr vs ₹3,054.8Cr (▲24.23% YoY), PAT ₹2,002.7Cr vs ₹1,505.1Cr (▲33.07% YoY). EBITDA Margin 15.04% vs 14.02% (▲102bps).

Financials Positive

2026-05-20 17:58

Apollo Hospitals Enterprise Limited reported Standalone Revenue ₹2,438.5Cr vs ₹2,075.3Cr (▲17.6% YoY), EBITDA ₹595.5Cr vs ₹521.3Cr (▲14.2% YoY), PAT ₹382.4Cr vs ₹333.4Cr (▲14.7% YoY) for the quarter ended March 31, 2026. EBITDA Margin 24.4% vs 25.1% (▼70bps).

Business Update Positive

2026-05-19 11:36

ICRA Limited has affirmed the credit ratings for Apollo Hospitals Enterprise Ltd (AHEL). The long-term bank facility and instrument ratings are affirmed at 'ICRA AAA/Stable' for a total of ₹3,000 crores (₹2,052 crores long-term fund-based term loan and ₹948 crores long-term/short-term fund-based/non-fund-based unallocated limits). The short-term rating is affirmed at 'ICRA A1+'. This indicates very strong creditworthiness and a stable outlook for the company's financial obligations.

Financials Neutral

2026-05-16 11:48

Apollo Hospitals Enterprise Limited announced a conference call for investors and analysts on Thursday, May 21, 2026, at 3:00 PM IST. The call is scheduled to discuss the audited financial results for the quarter and year ended March 31, 2026. The financial results will be announced on Wednesday, May 20, 2026, and will be available on the company's website.

Business Update Neutral

2026-05-08 18:30

Apollo Hospitals Enterprise Limited received an order from the National Company Law Tribunal, Chennai Bench, dated May 5, 2026. The order pertains to a proposed composite scheme of arrangement involving Apollo Hospitals, Apollo Healthco, Keimed Private Limited, and Apollo Healthtech. The Tribunal modified the dates for convening meetings of Secured Creditors, Unsecured Creditors, and Equity Shareholders, rescheduling them to various dates in June 2026. The application was allowed and disposed of, confirming the scheme's procedural progression.

Business Update Positive

2026-04-27 18:59

Apollo Hospitals received an NCLT order on April 27, 2026, for its composite scheme of arrangement involving Apollo Healthco, Keimed, and Apollo Healthtech. The order allows convening of meetings for equity shareholders and unsecured creditors on May 27, 2026, and also orders the secured creditors meeting for the same date. This progresses the scheme.

Business Update Neutral

2026-04-18 10:37

Apollo Hospitals announced NCLT order dated April 15, 2026, on its composite scheme of arrangement. The Tribunal directed convening meetings of secured creditors, unsecured creditors, and equity shareholders on revised dates in May 2026 to consider the scheme, marking a step forward in the restructuring process, though a request to dispense with the secured creditor meeting was dismissed.

Routine Neutral

2026-04-10 18:33

New Filing detected. See link for details.

Business Update Positive

2026-04-10 15:27

Apollo Hospitals Enterprise Limited received the NCLT order on April 9, 2026 (dated March 26, 2026), approving the Composite Scheme of Arrangement involving the company and its subsidiaries Apollo Healthco, Keimed Private, and Apollo Healthtech.

Routine Neutral

2026-04-07 15:06

Apollo Hospitals Enterprise Limited filed compliance certificates under SEBI Regulation 74(5) for the quarter ended March 31, 2026, confirming the details of securities dematerialized and that the security certificates received were duly processed and registered.

Business Update Positive

2026-04-03 17:05

Apollo Hospitals Enterprise Ltd. announced that the NCLT, Chennai, on March 26, 2026, allowed the application for a composite scheme of arrangement involving Apollo Healthco, Keimed Private, and Apollo Healthtech. The Tribunal also directed convening meetings of shareholders and creditors to approve the Scheme.

Business Update Positive

2026-04-02 18:13

Apollo Hospitals' Board approved establishing a multi-speciality hospital at Dwarka, New Delhi, on 9.33 acres leased from DDA for 55 years. The project will be implemented in phases with an annual license fee of ₹33.3 Cr from the fifth year.

Business Update Neutral

2026-03-31 16:40

Apollo Hospitals' subsidiary Apollo Healthco Limited acquired 100% of newly incorporated Apollo Consumer Products Limited (an FMCG company) for INR 9.00 Lakhs. ACPL becomes a step-down subsidiary. The transaction is noted to have no significant impact on the listed entity.

Routine Neutral

2026-03-24 14:40

Apollo Hospitals announced the closure of its trading window from April 1, 2026, until 48 hours after the declaration of audited financial results for the quarter and year ended March 31, 2026, to comply with SEBI Insider Trading Regulations.

Business Update Positive

2026-03-23 12:34

Apollo Hospitals completed the acquisition of a 30.58% stake in its subsidiary, Apollo Health and Lifestyle Limited (AHLL), for ₹12,540.68 million. This increases its effective shareholding to 99.42%.

Business Update Neutral

2026-02-14 12:25

Apollo Hospitals announced the transcript of the presentation on unaudited financial results for the three and nine months ended December 31, 2025 (Q3 FY26) is available. The presentation was held on February 11, 2026, and the transcript link is provided in the filing.

Business Update Neutral

2026-02-12 09:45

Apollo Hospitals announced the availability of the audio recording of its Analyst Call on the financial results for the three and nine months ended December 31, 2025. The recording can be accessed via the provided link.

Financials Positive

2026-02-10 18:34

Consolidated Revenue ₹6,477.4Cr vs ₹5,536.2Cr (▲17% YoY), EBITDA ₹965.3Cr vs ₹760.1Cr (▲27% YoY), PAT ₹502.3Cr vs ₹372.1Cr (▲35% YoY). EBITDA Margin 14.9% vs 13.7% (▲120bps).

Financials Positive

2026-02-10 18:28

Consolidated Revenue ₹6,477.4Cr vs ₹5,536.2Cr (▲17% YoY), EBITDA ₹965.3Cr vs ₹759.9Cr (▲27% YoY), PAT ₹502.3Cr vs ₹372.1Cr (▲35% YoY). EBITDA Margin 14.9% vs 13.7% (▲120bps).

Financials Positive

2026-02-10 18:28

Consolidated Revenue ₹6,477.4Cr vs ₹5,536.2Cr (▲17% YoY), EBITDA ₹965.3Cr vs ₹759.9Cr (▲27% YoY), PAT ₹502.3Cr vs ₹372.1Cr (▲35% YoY). EBITDA Margin 14.9% vs 13.7% (▲120bps).

Business Update Positive

2026-02-10 18:24

Apollo Hospitals' subsidiary acquired Belenus Champion Hospitals for Rs 1,650 million. Belenus, a 125-bed Bangalore hospital, is being upgraded to a 175-bed multi-speciality hospital, set to reopen by Q1 FY27, with an overall project cost of Rs 3,000 million.

Financials Positive

2026-02-10 18:13

Standalone Revenue from operations ₹2,363.7Cr vs ₹2,054.8Cr (▲15.03% YoY), EBITDA ₹593.5Cr vs ₹511.8Cr (▲16.03% YoY), PAT ₹383.5Cr vs ₹341.6Cr (▲12.26% YoY). EBITDA Margin 24.0% vs 23.7% (▲30bps). The Board also declared an interim dividend of Rs.10/- per share.

Financials Positive

2026-02-10 18:04

Standalone Revenue ₹2,363.7Cr vs ₹2,054.8Cr (▲15.03% YoY), EBITDA ₹593.5Cr vs ₹511.8Cr (▲15.96% YoY), PAT ₹383.5Cr vs ₹341.6Cr (▲12.26% YoY). EBITDA Margin 24.01% vs 23.66% (▲35bps). An interim dividend of Rs.10/- per share was declared.

Financials Positive

2026-02-10 17:51

Consolidated Total Income ₹6,530.2Cr vs ₹5,590.7Cr (▲16.8% YoY), EBITDA ₹961Cr vs ₹766.8Cr (▲25.3% YoY), PAT ₹516.3Cr vs ₹379.4Cr (▲36.1% YoY). EBITDA Margin 14.72% vs 13.71% (▲101bps). Additionally, an interim dividend of Rs.10/- per share was declared.

Financials Neutral

2026-01-30 10:53

Apollo Hospitals Enterprise Ltd. will hold an investor conference call on February 11, 2026, at 2:00 p.m. IST to discuss unaudited financial results for the quarter and nine months ended December 31, 2025, which will be announced on February 10, 2026.

Financials Positive

2026-01-27 18:19

CRISIL Ratings reaffirmed Apollo Hospitals Enterprise Ltd's long-term rating at 'CRISIL AA+' with the outlook revised to Positive from Stable, and short-term rating at 'CRISIL A1+' on January 27, 2026 for bank facilities of Rs. 2800 crores.

APOLLOHOSP

Apollo Hospitals Enterprise Limited

Filing History

Unlock Full History